States have been increasingly creating more stringent consumer data protections as it becomes easier to access sensitive patient health data digitally (ChatGPT’s new health tool, anyone?).

That is, except New York. Because on Dec. 19, Gov. Kathy Hochul vetoed the New York Health Information Privacy Act (NYHIPA), which had passed through the state’s Legislature in January 2025.

The law would have given patients more control over their health data that isn’t protected under the federal Health Insurance Portability and Accountability Act (HIPAA), which largely covers privacy in a pre-digital healthcare landscape, and it would have impacted any organizations or individuals processing a New York resident’s health information.

In her veto memo, Hochul wrote that “while well intentioned, the bill’s definitions and scope are broad, creating potentially significant uncertainty about the information subject to regulation and compliance challenges for consumers, businesses, and nonprofits.”

So, what next?—NO

December 2025 was a month full of holidays, time with loved ones—and, most importantly, medical device recalls.

The FDA gets 2+ million reports of deaths, injuries, and malfunctions associated with medical devices every year. Sometimes, these events prompt a recall ranging from Class III (least dangerous) to Class I (most dangerous). These recalls contain instructions that can range from small corrections to ending a device’s distribution.

We keep you informed on some recent Class I recalls here in our monthly series. Without further ado, welcome to the final Recall Roundup of 2025!

Anesthesia anomaly. Some power management boards for GE HealthCare Carestation 600 and 700 series anesthesia systems are at risk of unexpected shutdown. GE gave users special instructions on how to continue to use the anesthesia systems despite this issue and how to troubleshoot if the device shuts down.

See the full list here.—CC

The 44th annual JPMorgan Healthcare Conference wrapped up today. Hold the tears!

As investors and biotech founders alike head home, we at Healthcare Brew have a rundown on the biggest news from the week. Let’s get into it.

• Likely the most prominent announcement was a partnership between pharma and tech giants Eli Lilly and Nvidia. Together, the companies are creating an AI Co‑Innovation Lab in San Francisco and funding it with up to $1 billion over the next five years.
• Major federal health officials, such as FDA Commissioner Marty Makary and a roundtable of Centers for Medicare and Medicaid Services leaders, including Administrator Mehmet Oz, spoke at off-the-record keynotes throughout the week. We were in attendance and can confirm that a lot of the conversations highlighted the Trump administration’s Make America Healthy Again and Most Favored Nation agendas.
• In a bit of a non-announcement, attendees held their breath for big M&A news that never came. Fierce Biotech reported that companies don’t wait for major conferences to make these deals anymore, suggesting the conference’s purpose may shift in the future.
• Health companies did make some smaller announcements, though. Biotech Novartis, for example, announced one deal to acquire a peptide medication with Zonsen PepLib Biotech and another with SciNeuro Pharmaceuticals for an Alzheimer’s treatment.
• Wearable company Oura announced a partnership with online supplement company Fullscript to put users’ wearable ring data directly into the virtual care platform. The idea is to empower providers to use biometric data to make clinical decisions.
• Health information network Surescripts and GoodRx also formed a partnership this week to launch Script Corner, a new section of the drug marketplace’s site that will provide more drug price transparency to patients.
• Biotech AstraZeneca agreed to acquire startup Modella AI, which uses AI for drug discovery, on Jan. 13.

That’s all for now, but stay tuned for more from us down the line.—CM

The feeling of getting a 5/5 on the Brew’s weekly news quiz has been compared to getting a company-wide shoutout from your boss. It’s that satisfying.

Real jobs, shared through real communities. CollabWORK brings opportunities directly to Healthcare Brew readers—no mass postings, no clutter, just roles worth seeing. Click here to view the full job board.

• Contract Administrator - Strategic Sourcing at Seattle Children's
• Assoc. Director, Quality Value Stream Lead- Bulk/Fractionation at CSL Behring
• Director of Nursing at Bridgepointe Health Campus
• Clinical Supervisor at Hartford HealthCare
• Director Nursing - Women's and Children's Services at Providence